Advance Nanotech joins EC's FLUTEST avian flu project
7 December 2006
New York, USA. The European Commission has selected Advance Nanotech, Inc.,
(OTCBB:AVNA), to participate in FLUTEST, one of 17 projects in a programme
of avian and pandemic influenza research.
Collaborating with the University of Cambridge’s Centre for Advanced
Photonics and Electronics (CAPE), Advance Nanotech joins a consortium of
elite government labs in Europe, South Africa, and the USA led by the
Veterinary Laboratories Agency DEFRA, to develop, evaluate and validate
diagnostic tools to aid in the early detection of avian influenza — commonly
known as "bird flu".
The European Commission has committed $37.7 million
of new projects into avian and pandemic influenza. The new projects cover
human and animal health, and address research needs identified by
organizations such as the World Health Organization, the World Organization
for Animal Health and the Food & Agriculture Organization of the UN. The
€28.3 million allocated to these projects comes in addition to the $28
million previously made available by the European Commission.
with FLUTEST, Advance Nanotech's CAPE BiMAT program, is developing
technology to enable first responders — medics, EMTs and doctors — to
instantly analyze microscopic amounts of biological material on site. BiMAT
technology will eliminate the need to send samples to specialized
laboratories, speeding treatment and reducing problems of sample handling,
storage, and mislabeling that can cause significant delays in treatment.
Advance Nanotech’s BiMAT technology may also be customized for the detection
of other diseases such as E. Coli.
"We are honoured that DEFRA and
the European Commission recognize the potential of our BiMAT technology to
detect, and thus, help control, infectious diseases," said Tony Goncalves,
CEO of Advance Nanotech. "In the effort to combat the spread of avian
influenza, and infectious disease in general, there is a critical need for
inexpensive, field-deployable biosensors. The support received from the
European Commission will significantly shorten BiMAT's time-to-market for
the surveillance of emerging diseases such as avian influenza in remote
locations allowing rapid response and containment of these diseases."
World Health Organization, the United Nations specialized agency for health,
coordinates the global response to human cases of H5N1 avian influenza and
monitoring the corresponding threat of an influenza pandemic. Since 2003,
the H5N1 virus has killed more than 100 people and millions of birds
worldwide, sparking fears that the virus could mutate into a pandemic
BiMAT is part of Advance Nanotech's Homeland Security Division
which includes nanotechnologies providing solutions across two application
areas: CBRNE Detection (Chemical, Biological, Radiation, Nuclear, and
Explosive), and Wireless Monitoring for cognitive awareness, triage and
first response therapy. This division launched its first product earlier
this year, recently reported revenues for the first time and has a customer
base across the defence and industrial process control industries.
More information on
EC avian flu projects >>